LipoScience Company
LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.
.jpg)
.jpg)
.jpg)
Technology:
Other
Industry:
P4 Medicine
Headquarters:
Others
Founded Date:
1994-01-01
Employees Number:
251-500
Funding Status:
M&A
Investors Number:
9
Total Funding:
$28M
Last Funding Type:
Series F
Register and Claim Ownership